The  ||| S:0 E:4 ||| DT
impact  ||| S:4 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
bariatric  ||| S:14 E:24 ||| JJ
surgery  ||| S:24 E:32 ||| NN
on  ||| S:32 E:35 ||| IN
renal  ||| S:35 E:41 ||| JJ
and  ||| S:41 E:45 ||| CC
cardiac  ||| S:45 E:53 ||| JJ
functions  ||| S:53 E:63 ||| NNS
in  ||| S:63 E:66 ||| IN
morbidly  ||| S:66 E:75 ||| JJ
obese  ||| S:75 E:81 ||| JJ
patients  ||| S:81 E:90 ||| NNS
Cardiac  ||| S:90 E:98 ||| JJ
adaptation  ||| S:98 E:109 ||| NN
to  ||| S:109 E:112 ||| TO
obesity  ||| S:112 E:120 ||| NN
includes  ||| S:120 E:129 ||| VBZ
both  ||| S:129 E:134 ||| DT
structural  ||| S:134 E:145 ||| JJ
and  ||| S:145 E:149 ||| CC
functional  ||| S:149 E:160 ||| JJ
alterations  ||| S:160 E:172 ||| NN
in  ||| S:172 E:175 ||| IN
the  ||| S:175 E:179 ||| DT
heart ||| S:179 E:184 ||| NN
.  ||| S:184 E:186 ||| .
The  ||| S:186 E:190 ||| DT
kidneys  ||| S:190 E:198 ||| NN
also  ||| S:198 E:203 ||| RB
suffer  ||| S:203 E:210 ||| VB
the  ||| S:210 E:214 ||| DT
consequence  ||| S:214 E:226 ||| NN
of  ||| S:226 E:229 ||| IN
excessive  ||| S:229 E:239 ||| JJ
increase  ||| S:239 E:248 ||| NN
of  ||| S:248 E:251 ||| IN
body  ||| S:251 E:256 ||| NN
weight ||| S:256 E:262 ||| NN
.  ||| S:262 E:264 ||| .
This  ||| S:264 E:269 ||| DT
study  ||| S:269 E:275 ||| NN
aims  ||| S:275 E:280 ||| VBZ
to  ||| S:280 E:283 ||| TO
assess  ||| S:283 E:290 ||| VB
the  ||| S:290 E:294 ||| DT
functional ||| S:294 E:304 ||| NN
,  ||| S:304 E:306 ||| ,
cardiac  ||| S:306 E:314 ||| JJ
and  ||| S:314 E:318 ||| CC
renal  ||| S:318 E:324 ||| JJ
changes  ||| S:324 E:332 ||| NNS
in  ||| S:332 E:335 ||| IN
a  ||| S:335 E:337 ||| DT
cohort  ||| S:337 E:344 ||| NN
of  ||| S:344 E:347 ||| IN
morbidly  ||| S:347 E:356 ||| JJ
obese  ||| S:356 E:362 ||| JJ
patients ||| S:362 E:370 ||| NNS
,  ||| S:370 E:372 ||| ,
as  ||| S:372 E:375 ||| RB
well  ||| S:375 E:380 ||| RB
as  ||| S:380 E:383 ||| IN
changes  ||| S:383 E:391 ||| NNS
after  ||| S:391 E:397 ||| IN
bariatric  ||| S:397 E:407 ||| JJ
surgery-the  ||| S:407 E:419 ||| JJ
last  ||| S:419 E:424 ||| JJ
therapeutic  ||| S:424 E:436 ||| JJ
option  ||| S:436 E:443 ||| NN
for  ||| S:443 E:447 ||| IN
these  ||| S:447 E:453 ||| DT
patients ||| S:453 E:461 ||| NNS
.  ||| S:461 E:463 ||| .
Patients  ||| S:463 E:472 ||| NNS
referred  ||| S:472 E:481 ||| VBD
for  ||| S:481 E:485 ||| IN
bariatric  ||| S:485 E:495 ||| JJ
surgery  ||| S:495 E:503 ||| NN
were  ||| S:503 E:508 ||| VBD
prospectively  ||| S:508 E:522 ||| RB
included ||| S:522 E:530 ||| VBD
.  ||| S:530 E:532 ||| .
In  ||| S:532 E:535 ||| IN
each  ||| S:535 E:540 ||| DT
case ||| S:540 E:544 ||| NN
,  ||| S:544 E:546 ||| ,
transthoracic  ||| S:546 E:560 ||| JJ
echocardiography  ||| S:560 E:577 ||| NN
and  ||| S:577 E:581 ||| CC
a  ||| S:581 E:583 ||| DT
blood  ||| S:583 E:589 ||| NN
test  ||| S:589 E:594 ||| NN
were  ||| S:594 E:599 ||| VBD
performed  ||| S:599 E:609 ||| VBN
before  ||| S:609 E:616 ||| IN
the  ||| S:616 E:620 ||| DT
procedure  ||| S:620 E:630 ||| NN
and  ||| S:630 E:634 ||| CC
repeated  ||| S:634 E:643 ||| VBD
1  ||| S:643 E:645 ||| CD
year  ||| S:645 E:650 ||| NN
after  ||| S:650 E:656 ||| IN
surgery ||| S:656 E:663 ||| NN
.  ||| S:663 E:665 ||| .
The  ||| S:665 E:669 ||| DT
estimation  ||| S:669 E:680 ||| NN
of  ||| S:680 E:683 ||| IN
the  ||| S:683 E:687 ||| DT
glomerular  ||| S:687 E:698 ||| JJ
filtration  ||| S:698 E:709 ||| JJ
rate  ||| S:709 E:714 ||| NN
( ||| S:714 E:715 ||| -LRB-
GFR ||| S:715 E:718 ||| NNP
)  ||| S:718 E:720 ||| -RRB-
was  ||| S:720 E:724 ||| VBD
addressed  ||| S:724 E:734 ||| VBN
by  ||| S:734 E:737 ||| IN
the  ||| S:737 E:741 ||| DT
Cockroft-Gault  ||| S:741 E:756 ||| JJ
lean  ||| S:756 E:761 ||| JJ
body  ||| S:761 E:766 ||| NN
weight  ||| S:766 E:773 ||| NN
formula ||| S:773 E:780 ||| NN
.  ||| S:780 E:782 ||| .
Sixty-one  ||| S:782 E:792 ||| JJ
patients  ||| S:792 E:801 ||| NNS
completed  ||| S:801 E:811 ||| VBD
the  ||| S:811 E:815 ||| DT
1-year  ||| S:815 E:822 ||| NNP
follow-up ||| S:822 E:831 ||| NNP
.  ||| S:831 E:833 ||| .
Of  ||| S:833 E:836 ||| IN
these ||| S:836 E:841 ||| DT
,  ||| S:841 E:843 ||| ,
81.9 ||| S:843 E:847 ||| CD
%  ||| S:847 E:849 ||| NN
were  ||| S:849 E:854 ||| VBD
female ||| S:854 E:860 ||| JJ
.  ||| S:860 E:862 ||| .
The  ||| S:862 E:866 ||| DT
mean  ||| S:866 E:871 ||| JJ
age  ||| S:871 E:875 ||| NN
was  ||| S:875 E:879 ||| VBD
41.1  ||| S:879 E:884 ||| CD
±  ||| S:884 E:886 ||| CD
9.8  ||| S:886 E:890 ||| CD
years  ||| S:890 E:896 ||| NNS
and  ||| S:896 E:900 ||| CC
the  ||| S:900 E:904 ||| DT
mean  ||| S:904 E:909 ||| JJ
body  ||| S:909 E:914 ||| NN
mass  ||| S:914 E:919 ||| NN
index  ||| S:919 E:925 ||| NN
was  ||| S:925 E:929 ||| VBD
47.4  ||| S:929 E:934 ||| CD
±  ||| S:934 E:936 ||| CD
5  ||| S:936 E:938 ||| CD
kg ||| S:938 E:940 ||| CD
/ ||| S:940 E:941 ||| CD
m ||| S:941 E:942 ||| NNS
( ||| S:942 E:943 ||| -LRB-
2 ||| S:943 E:944 ||| LS
) ||| S:944 E:945 ||| -RRB-
,  ||| S:945 E:947 ||| ,
decreasing  ||| S:947 E:958 ||| VBG
to  ||| S:958 E:961 ||| TO
30.5  ||| S:961 E:966 ||| CD
±  ||| S:966 E:968 ||| CD
5.07  ||| S:968 E:973 ||| CD
kg ||| S:973 E:975 ||| CD
/ ||| S:975 E:976 ||| CD
m ||| S:976 E:977 ||| NNS
( ||| S:977 E:978 ||| -LRB-
2 ||| S:978 E:979 ||| LS
)  ||| S:979 E:981 ||| -RRB-
after  ||| S:981 E:987 ||| IN
the  ||| S:987 E:991 ||| DT
procedure ||| S:991 E:1000 ||| NN
.  ||| S:1000 E:1002 ||| .
Before  ||| S:1002 E:1009 ||| IN
surgery ||| S:1009 E:1016 ||| NN
,  ||| S:1016 E:1018 ||| ,
the  ||| S:1018 E:1022 ||| DT
estimated  ||| S:1022 E:1032 ||| JJ
GFR  ||| S:1032 E:1036 ||| NNP
was  ||| S:1036 E:1040 ||| VBD
92.7  ||| S:1040 E:1045 ||| CD
±  ||| S:1045 E:1047 ||| CD
25.4  ||| S:1047 E:1052 ||| CD
mL ||| S:1052 E:1054 ||| JJ
/ ||| S:1054 E:1055 ||| CD
min ||| S:1055 E:1058 ||| NN
,  ||| S:1058 E:1060 ||| ,
with  ||| S:1060 E:1065 ||| IN
hyperfiltration  ||| S:1065 E:1081 ||| NNS
being  ||| S:1081 E:1087 ||| VBG
present  ||| S:1087 E:1095 ||| JJ
in  ||| S:1095 E:1098 ||| IN
14.8 ||| S:1098 E:1102 ||| CD
%  ||| S:1102 E:1104 ||| NN
of  ||| S:1104 E:1107 ||| IN
patients ||| S:1107 E:1115 ||| NNS
,  ||| S:1115 E:1117 ||| ,
whereas  ||| S:1117 E:1125 ||| IN
an  ||| S:1125 E:1128 ||| DT
impaired  ||| S:1128 E:1137 ||| JJ
GFR  ||| S:1137 E:1141 ||| NNP
was  ||| S:1141 E:1145 ||| VBD
detected  ||| S:1145 E:1154 ||| VBN
in  ||| S:1154 E:1157 ||| IN
8.3 ||| S:1157 E:1160 ||| CD
% ||| S:1160 E:1161 ||| NN
.  ||| S:1161 E:1163 ||| .
Patients  ||| S:1163 E:1172 ||| NNS
showed  ||| S:1172 E:1179 ||| VBD
preserved  ||| S:1179 E:1189 ||| VBN
systolic  ||| S:1189 E:1198 ||| JJ
function  ||| S:1198 E:1207 ||| NN
and  ||| S:1207 E:1211 ||| CC
cardiac  ||| S:1211 E:1219 ||| JJ
remodelling ||| S:1219 E:1230 ||| NN
.  ||| S:1230 E:1232 ||| .
Diastolic  ||| S:1232 E:1242 ||| JJ
function  ||| S:1242 E:1251 ||| NN
was  ||| S:1251 E:1255 ||| VBD
abnormal  ||| S:1255 E:1264 ||| VBN
in  ||| S:1264 E:1267 ||| IN
27.9 ||| S:1267 E:1271 ||| CD
%  ||| S:1271 E:1273 ||| NN
of  ||| S:1273 E:1276 ||| IN
patients ||| S:1276 E:1284 ||| NNS
.  ||| S:1284 E:1286 ||| .
At  ||| S:1286 E:1289 ||| IN
the  ||| S:1289 E:1293 ||| DT
1-year  ||| S:1293 E:1300 ||| NNP
follow-up ||| S:1300 E:1309 ||| NNP
,  ||| S:1309 E:1311 ||| ,
favourable  ||| S:1311 E:1322 ||| JJ
changes  ||| S:1322 E:1330 ||| NNS
in  ||| S:1330 E:1333 ||| IN
the  ||| S:1333 E:1337 ||| DT
left  ||| S:1337 E:1342 ||| JJ
ventricular  ||| S:1342 E:1354 ||| JJ
geometry  ||| S:1354 E:1363 ||| NN
and  ||| S:1363 E:1367 ||| CC
related  ||| S:1367 E:1375 ||| JJ
haemodynamic  ||| S:1375 E:1388 ||| JJ
status  ||| S:1388 E:1395 ||| NN
were  ||| S:1395 E:1400 ||| VBD
observed ||| S:1400 E:1408 ||| VBN
.  ||| S:1408 E:1410 ||| .
There  ||| S:1410 E:1416 ||| EX
was  ||| S:1416 E:1420 ||| VBD
no  ||| S:1420 E:1423 ||| DT
significant  ||| S:1423 E:1435 ||| JJ
change  ||| S:1435 E:1442 ||| NN
in  ||| S:1442 E:1445 ||| IN
the  ||| S:1445 E:1449 ||| DT
estimated  ||| S:1449 E:1459 ||| JJ
GFR  ||| S:1459 E:1463 ||| NN
in  ||| S:1463 E:1466 ||| IN
the  ||| S:1466 E:1470 ||| DT
overall  ||| S:1470 E:1478 ||| JJ
group ||| S:1478 E:1483 ||| NN
,  ||| S:1483 E:1485 ||| ,
although  ||| S:1485 E:1494 ||| IN
hyperfiltration  ||| S:1494 E:1510 ||| NN
was  ||| S:1510 E:1514 ||| VBD
ameliorated  ||| S:1514 E:1526 ||| VBN
in  ||| S:1526 E:1529 ||| IN
9.8 ||| S:1529 E:1532 ||| CD
%  ||| S:1532 E:1534 ||| NN
and  ||| S:1534 E:1538 ||| CC
a  ||| S:1538 E:1540 ||| DT
poor  ||| S:1540 E:1545 ||| JJ
GFR  ||| S:1545 E:1549 ||| NNP
was  ||| S:1549 E:1553 ||| VBD
improved  ||| S:1553 E:1562 ||| VBN
in  ||| S:1562 E:1565 ||| IN
3.3. ||| S:1565 E:1569 ||| CD
% ||| S:1569 E:1570 ||| NN
.  ||| S:1570 E:1572 ||| .
The  ||| S:1572 E:1576 ||| DT
improvement  ||| S:1576 E:1588 ||| NN
was  ||| S:1588 E:1592 ||| VBD
not  ||| S:1592 E:1596 ||| RB
associated  ||| S:1596 E:1607 ||| VBN
with  ||| S:1607 E:1612 ||| IN
changes  ||| S:1612 E:1620 ||| NNS
in  ||| S:1620 E:1623 ||| IN
either  ||| S:1623 E:1630 ||| DT
blood  ||| S:1630 E:1636 ||| NN
pressure  ||| S:1636 E:1645 ||| NN
or  ||| S:1645 E:1648 ||| CC
the  ||| S:1648 E:1652 ||| DT
BMI ||| S:1652 E:1655 ||| NNP
.  ||| S:1655 E:1657 ||| .
However ||| S:1657 E:1664 ||| RB
,  ||| S:1664 E:1666 ||| ,
in  ||| S:1666 E:1669 ||| IN
this  ||| S:1669 E:1674 ||| DT
group  ||| S:1674 E:1680 ||| NN
of  ||| S:1680 E:1683 ||| IN
patients  ||| S:1683 E:1692 ||| NNS
the  ||| S:1692 E:1696 ||| DT
amelioration  ||| S:1696 E:1709 ||| NN
of  ||| S:1709 E:1712 ||| IN
the  ||| S:1712 E:1716 ||| DT
GFR  ||| S:1716 E:1720 ||| NNP
was  ||| S:1720 E:1724 ||| VBD
associated  ||| S:1724 E:1735 ||| VBN
with  ||| S:1735 E:1740 ||| IN
an  ||| S:1740 E:1743 ||| DT
increased  ||| S:1743 E:1753 ||| JJ
stroke  ||| S:1753 E:1760 ||| NN
volume  ||| S:1760 E:1767 ||| NN
and  ||| S:1767 E:1771 ||| CC
improvement  ||| S:1771 E:1783 ||| NN
in  ||| S:1783 E:1786 ||| IN
diastolic  ||| S:1786 E:1796 ||| JJ
function ||| S:1796 E:1804 ||| NN
.  ||| S:1804 E:1806 ||| .
In  ||| S:1806 E:1809 ||| IN
morbidly  ||| S:1809 E:1818 ||| JJ
obese  ||| S:1818 E:1824 ||| JJ
patients ||| S:1824 E:1832 ||| NNS
,  ||| S:1832 E:1834 ||| ,
GFR  ||| S:1834 E:1838 ||| NNP
is  ||| S:1838 E:1841 ||| VBZ
usually  ||| S:1841 E:1849 ||| RB
normal  ||| S:1849 E:1856 ||| JJ
and  ||| S:1856 E:1860 ||| CC
only  ||| S:1860 E:1865 ||| RB
a  ||| S:1865 E:1867 ||| DT
small  ||| S:1867 E:1873 ||| JJ
percentage  ||| S:1873 E:1884 ||| NN
of  ||| S:1884 E:1887 ||| IN
them  ||| S:1887 E:1892 ||| PRP
show  ||| S:1892 E:1897 ||| VBP
hyperfiltration  ||| S:1897 E:1913 ||| VBN
or  ||| S:1913 E:1916 ||| CC
a  ||| S:1916 E:1918 ||| DT
reduced  ||| S:1918 E:1926 ||| JJ
GFR ||| S:1926 E:1929 ||| NNP
.  ||| S:1929 E:1931 ||| .
Bariatric  ||| S:1931 E:1941 ||| JJ
surgery  ||| S:1941 E:1949 ||| NN
has  ||| S:1949 E:1953 ||| VBZ
a  ||| S:1953 E:1955 ||| DT
favourable  ||| S:1955 E:1966 ||| JJ
impact  ||| S:1966 E:1973 ||| NN
on  ||| S:1973 E:1976 ||| IN
renal  ||| S:1976 E:1982 ||| JJ
function  ||| S:1982 E:1991 ||| NN
in  ||| S:1991 E:1994 ||| IN
only  ||| S:1994 E:1999 ||| RB
a  ||| S:1999 E:2001 ||| DT
reduced  ||| S:2001 E:2009 ||| JJ
group  ||| S:2009 E:2015 ||| NN
of  ||| S:2015 E:2018 ||| IN
patients  ||| S:2018 E:2027 ||| NNS
who  ||| S:2027 E:2031 ||| WP
also  ||| S:2031 E:2036 ||| RB
experience  ||| S:2036 E:2047 ||| VB
an  ||| S:2047 E:2050 ||| DT
improvement  ||| S:2050 E:2062 ||| NN
in  ||| S:2062 E:2065 ||| IN
cardiac  ||| S:2065 E:2073 ||| JJ
performance ||| S:2073 E:2084 ||| NN
.  ||| S:2084 E:2086 ||| .
